Integrated Efficacy of FMX101 4% Topical Minocycline Foam for the Treatment of Moderate-to-Severe Acne Vulgaris: Analyses of Efficacy in Clinically Relevant Subgroups of Patients. J of Skin [Internet]. 2020 Oct. 27 [cited 2025 May 20];4(6):s89. Available from: https://skin.dermsquared.com/skin/article/view/1059